Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Investigational Site Number : 0560001, Leuven

Mount Sinai - Union Square Site Number : 8400002, New York

Investigational Site Number : 3800002, Torino

Investigational Site Number : 2760004, Berlin

Investigational Site Number : 2500002, Marseille

Investigational Site Number : 2500007, Caen

Penn State Milton S. Hershey Medical Center Site Number : 8400004, Hershey

University of Pennsylvania Site Number : 8400021, Philadelphia

Thomas Jefferson University Hospital Site Number : 8400014, Philadelphia

Georgetown University Medical Center Site Number : 8400020, Washington D.C.

Investigational Site Number : 3800001, Milan

Investigational Site Number : 3800004, Milan

Johns Hopkins University Site Number : 8400028, Baltimore

Investigational Site Number : 2760002, Lübeck

Investigational Site Number : 7240003, Madrid

Investigational Site Number : 2760005, Hanover

Mayo Clinic Site Number : 8400029, Jacksonville

AdventHealth Medical Group - Neurology at Winter Park Site Number : 8400006, Winter Park

Investigational Site Number : 2500003, Montpellier

Investigational Site Number : 2500004, Tours

Investigational Site Number : 7240001, Valencia

Froedtert Hospital & Medical College of Wisconsin Site Number : 8400010, Milwaukee

Investigational Site Number : 2500005, Vandœuvre-lès-Nancy

Investigational Site Number : 2500006, Lille

Northwestern Medical Group, Department of Neurology Site Number : 8400003, Chicago

University of Colorado Site Number : 8400025, Aurora

Investigational Site Number : 2760008, Haag in OB

University of Utah Site Number : 8400009, Salt Lake City

Investigational Site Number : 2760001, Ulm

USC Site Number : 8400008, Los Angeles

UC San Diego Health Site Number : 8400022, La Jolla

University of California Irvine Site Number : 8400012, Orange

California Pacific Medical Center Site Number : 8400015, San Francisco

Investigational Site Number : 2760009, Würzburg

Investigational Site Number : 1560001, Beijing

Investigational Site Number : 1560002, Hangzhou

Investigational Site Number : 1560004, Wuhan

Investigational Site Number : 1560005, Guangzhou

Investigational Site Number : 1560003, Chengdu

Investigational Site Number : 1560006, Xi'an

Massachusetts General Hospital Site Number : 8400001, Boston

Investigational Site Number : 1240004, Edmonton

Investigational Site Number : 1240007, Hamilton

Investigational Site Number : 1240006, London

Investigational Site Number : 1240008, Toronto

Investigational Site Number : 1240002, Montreal

Investigational Site Number : 1240001, Québec

Investigational Site Number : 2760003, Dresden

Investigational Site Number : 3920003, Nagoya

Investigational Site Number : 3920004, Ichikawa-shi

Investigational Site Number : 3920006, Tokushima

Investigational Site Number : 3920005, Fuchu-shi

Investigational Site Number : 3920001, Ōta-ku

Investigational Site Number : 3920002, Koshi-shi

Investigational Site Number : 5280001, Utrecht

Investigational Site Number : 6160001, Krakow

Investigational Site Number : 6160002, Ksawerów

Investigational Site Number : 7240005, Barcelona

Investigational Site Number : 7240002, L'Hospitalet de Llobregat

Investigational Site Number : 7520002, Stockholm

Investigational Site Number : 7520001, Umeå

Investigational Site Number : 8260002, Plymouth

Investigational Site Number : 8260003, Stoke-on-Trent